Literature DB >> 31852718

The Cytosolic DNA-Sensing cGAS-STING Pathway in Cancer.

John Kwon1, Samuel F Bakhoum2,3.   

Abstract

The recognition of DNA as an immune-stimulatory molecule is an evolutionarily conserved mechanism to initiate rapid innate immune responses against microbial pathogens. The cGAS-STING pathway was discovered as an important DNA-sensing machinery in innate immunity and viral defense. Recent advances have now expanded the roles of cGAS-STING to cancer. Highly aggressive, unstable tumors have evolved to co-opt this program to drive tumorigenic behaviors. In this review, we discuss the link between the cGAS-STING DNA-sensing pathway and antitumor immunity as well as cancer progression, genomic instability, the tumor microenvironment, and pharmacologic strategies for cancer therapy. SIGNIFICANCE: The cGAS-STING pathway is an evolutionarily conserved defense mechanism against viral infections. Given its role in activating immune surveillance, it has been assumed that this pathway primarily functions as a tumor suppressor. Yet, mounting evidence now suggests that depending on the context, cGAS-STING signaling can also have tumor and metastasis-promoting functions, and its chronic activation can paradoxically induce an immune-suppressive tumor microenvironment. ©2019 American Association for Cancer Research.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 31852718      PMCID: PMC7151642          DOI: 10.1158/2159-8290.CD-19-0761

Source DB:  PubMed          Journal:  Cancer Discov        ISSN: 2159-8274            Impact factor:   38.272


  151 in total

1.  Expanding the Role of STING in Cellular Homeostasis and Transformation.

Authors:  Jun Li; Samuel F Bakhoum
Journal:  Trends Cancer       Date:  2019-02-23

2.  STING agonist formulated cancer vaccines can cure established tumors resistant to PD-1 blockade.

Authors:  Juan Fu; David B Kanne; Meredith Leong; Laura Hix Glickman; Sarah M McWhirter; Edward Lemmens; Ken Mechette; Justin J Leong; Peter Lauer; Weiqun Liu; Kelsey E Sivick; Qi Zeng; Kevin C Soares; Lei Zheng; Daniel A Portnoy; Joshua J Woodward; Drew M Pardoll; Thomas W Dubensky; Young Kim
Journal:  Sci Transl Med       Date:  2015-04-15       Impact factor: 17.956

3.  Analysis of Drosophila STING Reveals an Evolutionarily Conserved Antimicrobial Function.

Authors:  Marina Martin; Aoi Hiroyasu; R Marena Guzman; Steven A Roberts; Alan G Goodman
Journal:  Cell Rep       Date:  2018-06-19       Impact factor: 9.423

Review 4.  Primary, Adaptive, and Acquired Resistance to Cancer Immunotherapy.

Authors:  Padmanee Sharma; Siwen Hu-Lieskovan; Jennifer A Wargo; Antoni Ribas
Journal:  Cell       Date:  2017-02-09       Impact factor: 41.582

5.  An immunosurveillance mechanism controls cancer cell ploidy.

Authors:  Laura Senovilla; Ilio Vitale; Isabelle Martins; Maximilien Tailler; Claire Pailleret; Mickaël Michaud; Lorenzo Galluzzi; Sandy Adjemian; Oliver Kepp; Mireia Niso-Santano; Shensi Shen; Guillermo Mariño; Alfredo Criollo; Alice Boilève; Bastien Job; Sylvain Ladoire; François Ghiringhelli; Antonella Sistigu; Takahiro Yamazaki; Santiago Rello-Varona; Clara Locher; Vichnou Poirier-Colame; Monique Talbot; Alexander Valent; Francesco Berardinelli; Antonio Antoccia; Fabiola Ciccosanti; Gian Maria Fimia; Mauro Piacentini; Antonio Fueyo; Nicole L Messina; Ming Li; Christopher J Chan; Verena Sigl; Guillaume Pourcher; Christoph Ruckenstuhl; Didac Carmona-Gutierrez; Vladimir Lazar; Josef M Penninger; Frank Madeo; Carlos López-Otín; Mark J Smyth; Laurence Zitvogel; Maria Castedo; Guido Kroemer
Journal:  Science       Date:  2012-09-28       Impact factor: 47.728

6.  Direct Activation of STING in the Tumor Microenvironment Leads to Potent and Systemic Tumor Regression and Immunity.

Authors:  Leticia Corrales; Laura Hix Glickman; Sarah M McWhirter; David B Kanne; Kelsey E Sivick; George E Katibah; Seng-Ryong Woo; Edward Lemmens; Tamara Banda; Justin J Leong; Ken Metchette; Thomas W Dubensky; Thomas F Gajewski
Journal:  Cell Rep       Date:  2015-05-07       Impact factor: 9.423

7.  Nivolumab for Recurrent Squamous-Cell Carcinoma of the Head and Neck.

Authors:  Robert L Ferris; George Blumenschein; Jerome Fayette; Joel Guigay; A Dimitrios Colevas; Lisa Licitra; Kevin Harrington; Stefan Kasper; Everett E Vokes; Caroline Even; Francis Worden; Nabil F Saba; Lara C Iglesias Docampo; Robert Haddad; Tamara Rordorf; Naomi Kiyota; Makoto Tahara; Manish Monga; Mark Lynch; William J Geese; Justin Kopit; James W Shaw; Maura L Gillison
Journal:  N Engl J Med       Date:  2016-10-08       Impact factor: 91.245

8.  Activation of STING-Dependent Innate Immune Signaling By S-Phase-Specific DNA Damage in Breast Cancer.

Authors:  Eileen E Parkes; Steven M Walker; Laura E Taggart; Nuala McCabe; Laura A Knight; Richard Wilkinson; Karen D McCloskey; Niamh E Buckley; Kienan I Savage; Manuel Salto-Tellez; Stephen McQuaid; Mary T Harte; Paul B Mullan; D Paul Harkin; Richard D Kennedy
Journal:  J Natl Cancer Inst       Date:  2016-10-05       Impact factor: 13.506

9.  PTBP1-Mediated Alternative Splicing Regulates the Inflammatory Secretome and the Pro-tumorigenic Effects of Senescent Cells.

Authors:  Athena Georgilis; Sabrina Klotz; Christopher J Hanley; Nicolas Herranz; Benedikt Weirich; Beatriz Morancho; Ana Carolina Leote; Luana D'Artista; Suchira Gallage; Marco Seehawer; Thomas Carroll; Gopuraja Dharmalingam; Keng Boon Wee; Marco Mellone; Joaquim Pombo; Danijela Heide; Ernesto Guccione; Joaquín Arribas; Nuno L Barbosa-Morais; Mathias Heikenwalder; Gareth J Thomas; Lars Zender; Jesús Gil
Journal:  Cancer Cell       Date:  2018-07-09       Impact factor: 31.743

10.  Mitochondrial inner membrane permeabilisation enables mtDNA release during apoptosis.

Authors:  Joel S Riley; Giovanni Quarato; Catherine Cloix; Jonathan Lopez; Jim O'Prey; Matthew Pearson; James Chapman; Hiromi Sesaki; Leo M Carlin; João F Passos; Ann P Wheeler; Andrew Oberst; Kevin M Ryan; Stephen Wg Tait
Journal:  EMBO J       Date:  2018-07-26       Impact factor: 11.598

View more
  161 in total

Review 1.  Decoding the rosetta stone of mitonuclear communication.

Authors:  Justin English; Jyung Mean Son; Maria Dafne Cardamone; Changhan Lee; Valentina Perissi
Journal:  Pharmacol Res       Date:  2020-08-23       Impact factor: 7.658

2.  The DNA Sensor cGAS is Decorated by Acetylation and Phosphorylation Modifications in the Context of Immune Signaling.

Authors:  Bokai Song; Todd M Greco; Krystal K Lum; Caroline E Taber; Ileana M Cristea
Journal:  Mol Cell Proteomics       Date:  2020-04-28       Impact factor: 5.911

Review 3.  Biomarker-Guided Development of DNA Repair Inhibitors.

Authors:  James M Cleary; Andrew J Aguirre; Geoffrey I Shapiro; Alan D D'Andrea
Journal:  Mol Cell       Date:  2020-05-26       Impact factor: 17.970

4.  Co-delivery of Peptide Neoantigens and Stimulator of Interferon Genes Agonists Enhances Response to Cancer Vaccines.

Authors:  Daniel Shae; Jessalyn J Baljon; Mohamed Wehbe; Plamen P Christov; Kyle W Becker; Amrendra Kumar; Naveenchandra Suryadevara; Carcia S Carson; Christian R Palmer; Frances C Knight; Sebastian Joyce; John T Wilson
Journal:  ACS Nano       Date:  2020-07-31       Impact factor: 15.881

Review 5.  Regulation and Consequences of cGAS Activation by Self-DNA.

Authors:  Christian Zierhut; Hironori Funabiki
Journal:  Trends Cell Biol       Date:  2020-06-13       Impact factor: 20.808

Review 6.  Optimizing Radiation Therapy to Boost Systemic Immune Responses in Breast Cancer: A Critical Review for Breast Radiation Oncologists.

Authors:  Alice Y Ho; Jean L Wright; Rachel C Blitzblau; Robert W Mutter; Dan G Duda; Larry Norton; Aditya Bardia; Laura Spring; Steven J Isakoff; Jonathan H Chen; Clemens Grassberger; Jennifer R Bellon; Sushil Beriwal; Atif J Khan; Corey Speers; Samantha A Dunn; Alastair Thompson; Cesar A Santa-Maria; Ian E Krop; Elizabeth Mittendorf; Tari A King; Gaorav P Gupta
Journal:  Int J Radiat Oncol Biol Phys       Date:  2020-05-14       Impact factor: 7.038

7.  STING negatively regulates allogeneic T-cell responses by constraining antigen-presenting cell function.

Authors:  Yongxia Wu; Chih-Hang Anthony Tang; Corey Mealer; David Bastian; M Hanief Sofi; Linlu Tian; Steven Schutt; Hee-Jin Choi; Taylor Ticer; Mengmeng Zhang; Xiaohui Sui; Lei Huang; Andrew L Mellor; Chih-Chi Andrew Hu; Xue-Zhong Yu
Journal:  Cell Mol Immunol       Date:  2021-01-26       Impact factor: 11.530

8.  Deubiquitinase USP35 restrains STING-mediated interferon signaling in ovarian cancer.

Authors:  Jiawen Zhang; Yunfei Chen; Xianfei Chen; Wen Zhang; Linlin Zhao; Linjun Weng; Hongling Tian; Zhiqiang Wu; Xiao Tan; Xin Ge; Ping Wang; Lan Fang
Journal:  Cell Death Differ       Date:  2020-07-16       Impact factor: 15.828

9.  MYC- and MIZ1-Dependent Vesicular Transport of Double-Strand RNA Controls Immune Evasion in Pancreatic Ductal Adenocarcinoma.

Authors:  Bastian Krenz; Anneli Gebhardt-Wolf; Carsten P Ade; Abdallah Gaballa; Florian Roehrig; Emilia Vendelova; Apoorva Baluapuri; Ursula Eilers; Peter Gallant; Luana D'Artista; Armin Wiegering; Georg Gasteiger; Mathias T Rosenfeldt; Stefan Bauer; Lars Zender; Elmar Wolf; Martin Eilers
Journal:  Cancer Res       Date:  2021-06-18       Impact factor: 12.701

10.  BCMA-Specific ADC MEDI2228 and Daratumumab Induce Synergistic Myeloma Cytotoxicity via IFN-Driven Immune Responses and Enhanced CD38 Expression.

Authors:  Lijie Xing; Su Wang; Jiye Liu; Tengteng Yu; Hailin Chen; Kenneth Wen; Yuyin Li; Liang Lin; Phillip A Hsieh; Shih-Feng Cho; Gang An; Lugui Qiu; Krista Kinneer; Nikhil Munshi; Kenneth C Anderson; Yu-Tzu Tai
Journal:  Clin Cancer Res       Date:  2021-10-01       Impact factor: 12.531

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.